Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.18 +0.01 (+0.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Other Accumulated Expenses (2023 - 2026)

Updated

Telomir Pharmaceuticals' Other Accumulated Expenses was $526.00 in Q2 2026, down 99.5% from $100,000 a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Other Accumulated Expenses at Telomir Pharmaceuticals came in at $318,234, up 240.6% from FY2024.

  • In earlier years, Other Accumulated Expenses was $93,432 in FY2024 (-82.3%) and $527,377 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Telomir Pharmaceuticals 81.15 Mn 81.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 526.00
Dec 31, 2025 318,234.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 93,432.00
Dec 31, 2023 527,377.00
API Access

Telomir Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=TELO&period=max&api_key=YOUR_API_KEY